Nav: Home

Slamming the brakes on the malaria life cycle

February 23, 2012

Scientists have discovered a new target in their fight against the devastating global disease 'malaria' thanks to the discovery of a new protein involved in the parasite's life cycle.

The research has uncovered a vital player in the sexual phase of the malaria parasite's reproduction which could prove an effective target for new treatments to stop the disease in its tracks.

The scientists from The University of Nottingham's School of Biology, with collaborators from the Universities of Leicester, Oxford, Imperial College London and Leiden in the Netherlands, have just published the results of their work in the journal PLoS Pathogens.

Biting back

Malaria is a devastating global disease with several hundred million clinical cases and just under a million people die from it every year. The disease is caused by an infection of the red blood cells with a tiny parasite called a Plasmodium, of which there are four important species. These organisms are carried from person to person by the Anopheles mosquito. When it bites an infected person, the mosquito sucks up blood containing the parasite, which may then be passed on to the mosquito's next victim.

Dr David Guttery, lead scientist of the paper and part of Dr Tewari's group from the University of Nottingham's Centre for Genetics and Genomics in the School of Biology said:

"The malaria parasite is a complex organism and to understand how it multiplies is crucial to stopping its transmission. Our study has identified a cell-division cycle gene in the malaria parasite and its role in the development of male sex cells and is hence a good candidate for putting the brakes on its development. We have shown that by deleting this gene, male gametes cannot form and burst out of their host cell (a process called exflagellation). Blocking the formation of these cells can be an important strategy in the prevention of malaria transmission from mosquito to mammalian hosts".

New Target

The protein that has been identified is called CDC20 and plays a part in the cell division cycle of the malaria parasite Plasmodium berghei which infects mice and rats. This gene has been shown to have an important role in cell division in many organisms, but up to now nothing has been known about its function in the malaria parasite. The new study provides the first description of the role of CDC20 in Plasmodium cell division and in the development of the malaria parasite's male sex cells (microgametes), which are essential for parasite transmission between humans and the mosquito carrier. The scientists have discovered that the absence of this gene stops the male sex cell from bursting out of its host cell and fertilising a female cell as they are arrested in their cell division.

The sexual stage of the malaria parasite's life-cycle occurs within the mosquito after it has fed on malaria-infected blood. This activates the parasite's sexual phase and during this period, the male sex cell precursor (microgametocyte) rapidly replicates it DNA and produces 8 male sex cells (gametes). These gametes then burst out of the microgametocyte in a process called exflagellation and seek out a female sex cell to fertilise. By blocking the process of exflagellation, the team have identified a way of slamming the brakes on malaria transmission.

The team of researchers were from the Centre of Genetics and Genomics at The University of Nottingham, the University of Oxford, Imperial College London, Leiden University, the University of Leicester and the MRC National Institute for Medical Research funded by the MRC, Wellcome Trust, and EviMalar.

The group at Nottingham has previously uncovered other major players in the life cycle of the malaria parasite. More details on these can be found in earlier media releases 'Stopping the spread of malaria' and 'Malaria research begins to bite'.
-end-
The new paper in PLoS Pathogens can be found online (after the embargo lifts) at: http://dx.plos.org/10.1371/journal.ppat.1002554

University of Nottingham

Related Malaria Articles:

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.
Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.
Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.
Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.
Seeking better detection for chronic malaria
In people with chronic malaria, certain metabolic systems in the blood change to support a long-term host-parasite relationship, a finding that is key to eventually developing better detection, treatment and eradication of the disease, according to research published today in the Journal of Clinical Investigation Insight.
Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.
Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.
The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.
Free malaria tests coupled with diagnosis-dependent vouchers for over-the-counter malaria treatment
Coupling free diagnostic tests for malaria with discounts on artemisinin combination therapy (ACT) when malaria is diagnosed can improve the rational use of ACTs and boost testing rates, according to a cluster-randomized trial published this week in PLOS Medicine by Wendy Prudhomme O'Meara of Duke University, USA, and colleagues.
Certain antibodies against a sugar are associated with malaria protection
Certain type of antibodies against α-Gal- a carbohydrate expressed by many organisms including the malaria parasite- could protect against malaria, according to a new study led by ISGlobal, an institution supported by 'la Caixa' Foundation.
More Malaria News and Malaria Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.